Vaccine Adjuvants for Infectious Diseases
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (20 August 2023) | Viewed by 297
Special Issue Editors
Interests: vaccine design; delivery systems; infectious diseases; molecular biology
Interests: vaccine delivery; antimicrobial peptides; infectious diseases; vaccine design
Special Issue Information
Dear Colleagues,
The difficulty of creating safe and efficient vaccines continues to be a barrier for treating many infectious diseases. Due to their lower immunogenicity when compared to whole pathogen vaccines, adjuvants are a crucial component in the creation of vaccines, particularly for inactivated and subunit-based vaccines. Although adjuvants come in a vast range of structural variations, they all serve the same purpose in vaccine constructs: to strengthen and/or extend the immune response. However, the possibility of negative consequences from the use of adjuvants must be recognized and properly managed. The sort of immunological response required for a specific vaccine should be taken into consideration when choosing an adjuvant because they have various mechanisms of action. As a result, thorough preclinical and clinical research is crucial for adjuvant development. Overall, the use of adjuvants increases opportunities for developing vaccines, and the significance of immune stimulants promotes the creation of new and improved adjuvants. Therefore, we would like to encourage the submission of recent findings (original research articles and reviews) about the potential benefits of various adjuvant types, their characteristics, and the processes by which they work in different vaccines for this Special Issue. It will be easier to explore new adjuvant formulations and create vaccines against infectious diseases if we have a better understanding of the current adjuvants.
Dr. Morteza Abkar
Dr. Mahdi Fasihi Ramandi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adjuvants
- vaccines
- immune response
- infectious disease
- delivery system
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
